Development: In Vivo Pharmacology—Systems Biology in Health and Disease II
作者： Aleš Prokop , Seth Michelson
DOI: 10.1007/978-94-007-2849-3_6
关键词: Disease 、 Biology 、 Pharmacology 、 In silico 、 In vivo 、 RNA interference 、 Systems biology 、 Xenobiotic receptor
摘要: This chapter covers qualitative in vivo approaches animals and man, which will help to develop silico pharmacology PK positions. Additionally, we cover RNA interference this even though it is largely an vitro method for characterizing the dynamics of cell physiology. And only a rudimentary state, vitally important clinical model based drug design (MBDD) development (see Chap. 10).
springer.com
sci-hub.se 参考文章(25)
Seth Michelson, The impact of systems biology and biosimulation on drug discovery and development Molecular BioSystems. ,vol. 2, pp. 288- 291 ,(2006) , 10.1039/B602194H
Angela Reynolds, Devin Leake, Queta Boese, Stephen Scaringe, William S Marshall, Anastasia Khvorova, Rational siRNA design for RNA interference Nature Biotechnology. ,vol. 22, pp. 326- 330 ,(2004) , 10.1038/NBT936
Jiehua Zhou, John J. Rossi, Aptamer-targeted RNAi for HIV-1 therapy. Methods of Molecular Biology. ,vol. 721, pp. 355- 371 ,(2011) , 10.1007/978-1-61779-037-9_22
Ann K Daly, Individualized drug therapy. Current Opinion in Drug Discovery & Development. ,vol. 10, pp. 29- 36 ,(2007)
Qing Yan, The Integration of Personalized and Systems Medicine Methods in Molecular Biology™. ,vol. 448, pp. 1- 19 ,(2008) , 10.1007/978-1-59745-205-2_1
Riccardo Colombo, Jürgen Moll, Target validation to biomarker development: focus on RNA interference. Molecular Diagnosis & Therapy. ,vol. 12, pp. 63- 70 ,(2008) , 10.1007/BF03256271
Daniel W Nebert, Lucia Jorge-Nebert, Elliot S Vesell, Pharmacogenomics and "individualized drug therapy": high expectations and disappointing achievements. American Journal of Pharmacogenomics. ,vol. 3, pp. 361- 370 ,(2003) , 10.2165/00129785-200303060-00002
Mark Lewandoski, Conditional control of gene expression in the mouse Nature Reviews Genetics. ,vol. 2, pp. 743- 755 ,(2001) , 10.1038/35093537
S.D.M. Brown, J.M. Hancock, The mouse genome. Genome dynamics. ,vol. 2, pp. 33- 45 ,(2006) , 10.1159/000095091
Volker Patzel, In silico selection of active siRNA Drug Discovery Today. ,vol. 12, pp. 139- 148 ,(2007) , 10.1016/J.DRUDIS.2006.11.015